Nanobiomimetic reagent-free technology
Advanced Biomimetic Sensors, Inc, MD, United States
Nanobiomimetic reagent-free technology is based on direct electrochemical communication between the sensor and the analyte without third party involved. It offers 0.1 Âµm3 spatial and 3 ms temporal resolution per image based on aWHr energy change at early asymptomatic stage diseases without environmental contamination and no protein interference.
Primary Application Area: Medical Devices
Technology Development Status: Prototype
Technology Readiness Level: TRL 5
FIGURES OF MERIT
Value Proposition: Patients requested to use our devices and distributors urgent sent orderings. The valuation is $10M: grants and owner’s initial investments, patents strength, industry recognition, expanded product lines in 5 markets. Projected total $117-240M in the future revenue within the future 10-15 years is expected.
Organization Type: Mid-stage Startup (A or B)
Showcase Booth #: 47T
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: ABS received HHS therapeutic discovery grant $105k for two years from 2010-2011 and Technology development fund of $40k from Montgomery County Economic Development Department of Maryland.
Primary Sources of Funding: Angel, Friends, Family, Venture Capital, Corporate Partner, Federal Grant
Looking for: Both Funding and Development Partners